PCM
CTIC

Pyrrho Capital Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Pyrrho Capital Management’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-60,819
Closed -$1.19M – 58
2015
Q2 		$1.19M Buy
+60,819
New +$1.17M 0.58% 20

Other funds holding CTIC

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Pyrrho Capital Management's CTIC Position: Q3 2015 in Review

Pyrrho Capital Management sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q3 2015, closing a stake of 60,819 shares — an estimated $1.19M sold.

Pyrrho Capital Management first reported a position in CTIC in Q2 2015 and held it in 1 quarter. The position peaked at $1.19M in Q2 2015. 86 funds tracked by Wall St. Rank hold CTIC as of Q3 2015.

  • Pyrrho Capital Management reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q3 2015 after selling out during the quarter.
  • Pyrrho Capital Management sold 60,819 CTI BioPharma Corp. (DE) Common Stock shares in Q3 2015, an estimated $1.19M.
  • Pyrrho Capital Management first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2015 and held it in 1 quarter.
  • Pyrrho Capital Management's CTI BioPharma Corp. (DE) Common Stock position peaked at $1.19M in Q2 2015.
  • 86 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q3 2015.

Based on Pyrrho Capital Management's 13F filing for Q3 2015, filed 3 Nov 2015.